Keywords
cervix cytology
Pap smear
age group
How to Cite
Abstract
The objective of this study was to identify the distribution of cytological diagnosis by means of Pap test on pre-neoplastic and neoplastic lesions from women at different age group in the period of 20 years. Retrospective survey of cytological cervicovaginal diagnoses was done to achieve this goal. Diagnoses results from 1,020,853 cytological samplings on Pap test, were studied according to age groups. In the period of 20 years from 1984 to 2003 the distribution of cervicovaginal cytological diagnoses according to age was analyzed four intervals of 5 year - (four quinquennia). Of analyzed cytological samples 27,314 (2.68%) were unsatisfactory, 980,985 (96.09%) were negative, and 12,554 (1.23%) resulted in squamous intraepithelial lesions and cancer. LSIL peak was observed within the four quinquennia and in the 20-24 age group, HSIL was most frequent in the 30-34 year age group, and SCC/ADENO Ca were present in women above 50 years old. In women of 15-19 years of age, a clear-increase in LSIL frequency was observed in four quinquennia, of 66 (9.19%) in the first quinquennium, 109 (9.83%) in the second, 441 (17.46%) in the third, and 467 (15.97%) in the last one. The outcome of the uterine cervix cancer prevention programs can be measured by the high frequency of LSIL type lesions in the past five years, and the data disclosed in the present study are in accordance with the data reported by the others from another continuous uterine cervix cancer prevention programs.References
1. Committee of cancer experts of the “Europe Against Cancer” Program European Guidelines for quality assurance in cervical cancer screening. Eur J Cancer 1993; 29A:S1 - S19.
2. Di Loreto C, Maeda MYS, Utagawa ML, Longatto-Filho A, AlvesVAF. Quality Warranty in Cytopathology: Aspects of the cyto-histologic correlation. Rev Ass Med Brazil 1997; 43(3):195-8.
3. Yamamoto LSU, Alves VAF, Maeda MYS, Longatto-Filho A, UtagawaML, Eluf-Neto J. A morphological protocol and guide-list on uterinecervix cytology associated to papillomavirus infection. Rev Inst Med Trop S Paulo 2004; 46(4):189-93.
4. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69:114-9.
5. Ferraz MGMC, Agnol MD, di Loreto C, Pirani WM, Utagawa ML,Pereira SMM, Sakai YI, Feres CL, Shih LWS, Yamamoto LSU, Rodrigues ROL, Shirata NK, Longatto-Filho A. 100% Rapid rescreeningfor quality assurance in a quality control program in a public healthcytologic laboratory. Acta Cytol 2005; 49(6):639-43.
6. Organização Mundial de la Salud. Manual de normas y procedimientos para el control del cancer del cuello uterino. Washington pp.16, 1994.
7. Ministério da Saúde do Brasil. Seminário sobre nomenclatura e controlede qualidade dos exames citológicos e prevenção do câncer cérvico-uterino. Rio de Janeiro, 1993.
8. Solomon D, Davey D, Kurman R, Moriarty A, O ́Connor D, Prey M,Raab S, Sherman M, Wilbur D, Wright Jr T, Young N. The 2001 Bethesda System. Terminology for reporting results of cervicalcytology. JAMA 2002; 287(16): 2114-9.
9. Fagundes MCS, Hardt LL, Saito S, Yamamoto LSU, Longatto-Filho A,Utagawa ML. Amostra inadequada em screening de esfregaços cérvico-vaginais: as principais causas. Laes & Haes 2001; 22(128): 94-100.
10. Nascimento CMR, Eluf-Neto J, Rego RA. Cobertura do Teste de Papanicolaou no município de São Paulo e características das mulheres que realizaram o teste. Bol Oficina Sanit Panam 1996; 121: 491-500.
11. Gupta PK. Benign Proliferative Reactions, Intraepithelial Neoplasia,and Invasive Cancer of the Uterine Cervix. In: Bibbo, M. Comprehensive Cytopathology. Philadelphia, Pennsylvania, EdSaunders Company pp 125-60, 1997.
12. Mount SL, Papillo JL. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in Northern New England. Pediatrics1999; 103: 539-44.
13. IARC Monographs on the Evaluation of Carcinogenic risk to Humans. Human Papillomaviruses. Vol 64, Lyon: International Agency forResearch on Cancer pp 82 -231, 1995.
14. Ministério da Saúde. Instituto Nacional do Câncer. Estimativas da incidência e mortalidade por câncer no Brasil. Rio de Janeiro, 2000.
15. Fender M, Schaffer P, Dellenbach P. Peut-on et faut-il organiser ledépistage du cancer du col de l’utérus en France? J Gynecol Obstet BiolReprod 1998; 27: 683-91.
16. Shirata NK, Pereira SMM, Cavaliere MJ, Longatto-Filho A, UtagawaML, Shih LWS, Maeda MYS. Celularidade dos esfregaços cérvico-vaginais: importância em programas de garantia de qualidade emcitopatologia. J bras Ginec 1998; 108(3): 63-6.
17. Utagawa ML, Pereira SMM, Cavaliere, MJ, Maeda MYS, Shih LWS,Shirata NK. Cervical intraepithelial neoplasia in adolescents: study of cytological finding between 1987 and 1995 in São Paulo State –Brazil. Arch Gynecol Obstet 1998; 262: 59-64.
18. Utagawa ML, Pereira SMM, Cavaliere MJ, Shirata NK. Lesõesprecursoras de câncer do colo uterino em adolescentes: impacto emsaúde pública. Folha Médica 2000; 4 (119): 55-8.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2006 Instituto Adolfo Lutz Journal